BioSpace News Archive

Drug Development

Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued Weight Loss at Up to Nine Months in Patients with HET Obesity on Setmelanotide at ENDO 2021

Additional poster presentations include Phase 3 data in Bardet-Biedl and Alström syndromes and analyses of adverse eventsin Phase 2 and Phase 3 studies in POMC, PCSK1, or LEPR deficiency showing consistent safety results for setmelanotide

March 20, 2021
·
11 min read
Genetown

Insulet’s Omnipod® 5 Automated Insulin Delivery System Improves Clinical Outcomes in Type 1 Diabetes

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced positive results from the first pivotal trial for the Omnipod® 5 Automated Insulin Delivery System.

March 20, 2021
·
6 min read
Policy

Statement from the Chief Public Health Officer of Canada on March 20, 2021

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

March 20, 2021
·
5 min read
Deals

Core One Labs Files Application to List its Common Shares on NASDAQ - Mar 20, 2021

Core One Labs Inc., is pleased to announce that it has filed an application to list its common shares on the Capital Market tier of The NASDAQ Stock Market LLC.

March 20, 2021
·
4 min read